The Uganda Cancer Institute (UCI) has issued an urgent public health warning, confirming that Prostate Cancer has become the most commonly diagnosed cancer among men in Uganda and remains a leading cause of cancer-related deaths. This escalating crisis demands immediate…
A new chapter for Uganda’s industrial and pharmaceutical landscape began in Busoga this week as H.E. President Yoweri Museveni commissioned the US$50 million (Shs182 billion) DEI BioPharma Starch Processing Factory in Busambu–Namasagali. This facility is the first phase of a…
Africa’s journey in battling devastating diseases like HIV/AIDS and malaria has been a story of resilience and hard-won progress. Yet, this progress is constantly threatened by a systemic issue that hampers access to life-saving medicines and stifles local industry: regulatory…
A defining moment for African health and scientific independence was announced at the 4th International Conference on Public Health in Africa (CPHIA 2025), as Dei BioPharma Founder Dr. Matthias Magoola revealed that the company has secured new patent rights for…
The Uganda Cancer Institute (UCI) has sounded a clear and urgent alarm this Breast Cancer Awareness Month: “Early Detection Saves Lives.” As the leading cancer among women in Uganda, the disease presents a formidable public health challenge, yet one that…
In a landmark announcement, a new and highly effective HIV prevention drug, Lenacapavir, is set to be made available at a drastically reduced cost in over 100 low- and middle-income countries within the next two years. This breakthrough development offers…
The Government of Uganda has launched an aggressive, multi-agency media campaign to combat the pervasive problem of drug theft, which is costing the nation billions of shillings and, more critically, human lives. Led by the National Medical Stores (NMS), the…
Uganda has been placed on high alert following the confirmation of a new Ebola virus outbreak in the Democratic Republic of Congo (DRC), which has already claimed at least 15 lives. While the latest outbreak is centered in the central…
The Uganda Cancer Institute (UCI) today launched the September Gold, Childhood Cancer Awareness Month, during which officials from the institute delivered a transformative message about cancer awareness among children in the country. Led by Dr. Joyce Balagadde Kambugu, the Head…
In a landmark achievement for African innovation, Dei BioPharma, a Ugandan pharmaceutical complex, has received a second major approval from the U.S. Food and Drug Administration (FDA), solidifying the country’s position as an emerging global hub for vital medicines. The…
In a landmark achievement that resonates beyond its borders, Uganda has positioned itself at the forefront of global medical innovation, as the United States Patent and Trademark Office (USPTO) has formally accepted two groundbreaking vaccine patent applications by Dr. Mathias…
Uganda is rapidly emerging as a significant regional player in pharmaceutical manufacturing, charting a course to promote healthcare access and capability across East Africa. This was the key message delivered by Hitesh Upreti, Chief Executive Officer of Dei BioPharma, at…
The Uganda Cancer Institute (UCI) has issued a critical national appeal, drawing urgent attention to the escalating burden of oesophageal cancer in the country. The Institute is calling on the public, health professionals, and policymakers to immediately prioritise awareness, early…
A landmark moment in the global fight against HIV has been cemented with the U.S. Food and Drug Administration (FDA) approval of lenacapavir, a groundbreaking “super drug” for HIV prevention, after pivotal trials conducted right here in Uganda. This twice-a-year…
A Ugandan student, Emmanuel Kiyonga, has made a groundbreaking discovery in the field of pharmaceuticals, developing a drug that cures breast cancer. The drug, named Raloxifene Hydrochloride Solvate-Hydrate, is the first patent secured by the university. Kiyonga, a pharmacy graduate…